newsfilter
← Latest News
GlobeNewswire·

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes

POMPANO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC:BSEM), a leading MedTech company specializing in placental-derived biologics for advanced wound care, today commented on the